Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Guardian Pharmacy ServicesGRDN +0.48%42 Market Cap is $2,374 Mil as of Aug. 27, 2026. GuruFocus rates GRDN with a GF Score™ of 42/100. Among 694 Healthcare Providers & Services companies, Guardian Pharmacy Services ranks better than 89.91% on this metric.
Guardian Pharmacy Services's quarterly market cap
increased
from Dec. 2025 ($1,905 Mil) to Mar. 2026 ($2,385 Mil) and
increased
from Mar. 2026 ($2,385 Mil) to Jun. 2026 ($2,652 Mil).
Guardian Pharmacy Services's annual market cap
increased
from Dec. 2023 ($0 Mil) to Dec. 2024 ($1,282 Mil) and
increased
from Dec. 2024 ($1,282 Mil) to Dec. 2025 ($1,905 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Guardian Pharmacy Services's Enterprise Value for Today is $2,332 Mil.
Guardian Pharmacy Services (NYSE:GRDN) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Guardian Pharmacy Services Market Cap Related Terms
Guardian Pharmacy Services Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Guardian Pharmacy Services's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guardian Pharmacy Services Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Guardian Pharmacy Services's Market Cap distribution charts can be found below:
* The bar in red indicates where Guardian Pharmacy Services's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guardian Pharmacy Services (GRDN) has a Market Cap of $2,374 Mil as of Aug. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Guardian Pharmacy Services and its competitors. According to the industry distribution chart, Guardian Pharmacy Services ranks #70 out of 694 companies in the Healthcare Providers & Services industry, placing it in the top 10.1%.
Is Guardian Pharmacy Services' Market Cap too high?
Guardian Pharmacy Services' current Market Cap is $2,374 Mil. The Healthcare Providers & Services industry median Market Cap is 110.16. Guardian Pharmacy Services' value of $2,374 Mil is 2055.1% above this industry median. Based on the distribution chart, Guardian Pharmacy Services ranks #70 out of 694 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Guardian Pharmacy Services has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Guardian Pharmacy Services' Market Cap compare to MD and ADUS?
According to the Healthcare Providers & Services industry distribution chart, Guardian Pharmacy Services ranks #70 out of 694 companies for Market Cap. This places Guardian Pharmacy Services in the top 10% of its industry — outperforming the majority of peers. The industry median Market Cap is 110.16. Guardian Pharmacy Services' value of $2,374 Mil is 2055.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 110.16, based on 694 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guardian Pharmacy Services's current Market Cap of $2,374 Mil is 2055.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Guardian Pharmacy Services and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 110.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guardian Pharmacy Services's current Market Cap is $2,374 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardian Pharmacy Services stock overvalued right now?
Guardian Pharmacy Services (GRDN) has a current Market Cap of $2,374 Mil. The current Market Cap is $2,374 Mil and 2055.1% above the Healthcare Providers & Services industry median of 110.16. Guardian Pharmacy Services' overall GF Score™ is 42/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Guardian Pharmacy Services (GRDN), the current Market Cap is $2,374 Mil as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
42GF Score
Get the complete analysis for GRDN
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRDN has been successfully added to your 
